Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery
Tóm tắt
Từ khóa
Tài liệu tham khảo
Reddi AH . Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998; 16: 247–252.
Wozney JM et al. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528–1534.
Hogan BL . Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580–1594.
Zou H et al. BMP signaling and vertebrate limb development. Cold Spring Harb Symp Quant Biol 1997; 62: 269–272.
Massague J, Weis-Garcia F . Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Cancer Surv 1996; 27: 41–64.
Yamashita H, Ten Dijke P, Heldin CH, Miyazono K . Bone morphogenetic protein receptors. Bone 1996; 19: 569–574.
Heldin CH, Miyazono K, ten Dijke P . TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465–471.
Heckman JD, Boyan BD, Aufdemorte TB, Abbott JT . The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg Am 1991; 73: 750–764.
Gerhart TN et al. Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. Clin Orthop 1993; 349: 317–326.
Lee SC et al. Healing of large segmental defects in rat femurs is aided by RhBMP-2 in PLGA matrix. J Biomed Mater Res 1994; 28: 1149–1156.
Bostrom MP, Camacho NP . Potential role of bone morphogenetic proteins in fracture healing. Clin Orthop 1998; 355 (Suppl): S274–S282.
Cheng SL et al. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcif Tissue Int 2001; 68: 87–94.
Krebsbach PH, Gu K, Franceschi RT, Rutherford RB . Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo (in process citation). Hum Gene Ther 2000; 11: 1201–1210.
Partridge K et al. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 2002; 292: 144–152.
Riew KD et al. Induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene in a rabbit spinal fusion model. Calcif Tissue Int 1998; 63: 357–360.
Varady P et al. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 2001; 12: 697–710.
Varady P et al. CT and radionuclide study of BMP-2 gene therapy-induced bone formation. Acad Radiol 2002; 9: 632–637.
Helm GA et al. Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg 2000; 92: 191–196.
Sandhu HS, Khan SN, Suh DY, Boden SD . Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: an overview. Eur Spine J 2001; 10 (Suppl. 2): S122–S131.
Boden SD, Zdeblick TA, Sandhu HS, Heim SE . The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000; 25: 376–381.
Friedlaender GE . OP-1 clinical studies. J Bone Joint Surg Am 2001; 83-A: S160–S161.
Valentin-Opran A et al. Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop 2002; 395: 110–120.
Whang K et al. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. J Biomed Mater Res 1998; 42: 491–499.
Alden TD et al. Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. J Neurosurg 1999; 90: 109–114.
Oyama M et al. Retrovirally transduced bone marrow stromal cells isolated from a mouse model of human osteogenesis imperfecta (oim) persist in bone and retain the ability to form cartilage and bone after extended passaging. Gene Therapy 1999; 6: 321–329.
Alden TD et al. In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther 1999; 10: 2245–2253.
Baltzer AW et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Therapy 2000; 7: 734–739.
Baltzer AW et al. Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clin Orthop 2000; 379 (Suppl): S120–S125.
Bosch P et al. The efficiency of muscle-derived cell-mediated bone formation. Cell Transplant 2000; 9: 463–470.
Breitbart AS et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 1999; 42: 488–495.
Franceschi RT, Wang D, Krebsbach PH, Rutherford RB . Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 2000; 78: 476–486.
Gazit D et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1999; 1: 121–133.
Lieberman JR et al. Regional gene therapy with a BMP-2-producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents. J Orthop Res 1998; 16: 330–339.
Lou J, Xu F, Merkel K, Manske P . Gene therapy: adenovirus-mediated human bone morphogenetic protein-2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo. J Orthop Res 1999; 17: 43–50.
Mason JM et al. Expression of human bone morphogenic protein 7 in primary rabbit periosteal cells: potential utility in gene therapy for osteochondral repair. Gene Therapy 1998; 5: 1098–1104.
Musgrave DS et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 1999; 24: 541–547.
Okubo Y et al. Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. Biochem Biophys Res Commun 2000; 267: 382–387.
Ripamonti U et al. Bone induction by BMPs/OPs and related family members in primates. J Bone Joint Surg Am 2001; 83-A: S116–S127.
Lee JY et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 2001; 83-A: 1032–1039.
Cheng H et al. Osteogenic activity of the 14 types of human bone morphogenetic proteins (BMPs). J Bone Joint Surgery Am 2003; 85-A: 1544–1552.
Robbins PD, Tahara H, Ghivizzani SC . Viral vectors for gene therapy. Trends Biotechnol 1998; 16: 35–40.
Kay MA, Glorioso JC, Naldini L . Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001; 7: 33–40.
Alemany R, Balague C, Curiel DT . Replicative adenoviruses for cancer therapy. Nat Biotechnol 2000; 18: 723–727.
Breyer B et al. Adenoviral vector-mediated gene transfer for human gene therapy. Curr Gene Ther 2001; 1: 149–162.
Thomas CE, Ehrhardt A, Kay MA . Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346–358.
Sun MH et al. Bone morphogenetic proteins and bone regeneration: from biology to clinical applications. Adv Osteoporotic Fract Manag 2003; 2: 70–78.
Bahamonde ME, Lyons KM . BMP3: to be or not to be a BMP. J Bone Joint Surg Am 2001; 83-A: S56–S62.
Lee JY et al. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum Gene Ther 2002; 13: 1201–1211.
Lieberman JR, Daluiski A, Einhorn TA . The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002; 84-A: 1032–1044.
Noda M, Camilliere JJ . In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 1989; 124: 2991–2994.
Joyce ME, Terek RM, Jingushi S, Bolander ME . Role of transforming growth factor-beta in fracture repair. Ann N Y Acad Sci 1990; 593: 107–123.
Lind M et al. Transforming growth factor-beta enhances fracture healing in rabbit tibiae. Acta Orthop Scand 1993; 64: 553–556.
Nielsen HM, Andreassen TT, Ledet T, Oxlund H . Local injection of TGF-beta increases the strength of tibial fractures in the rat. Acta Orthop Scand 1994; 65: 37–41.
Critchlow MA, Bland YS, Ashhurst DE . The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. Bone 1995; 16: 521–527.
Sumner DR et al. Enhancement of bone ingrowth by transforming growth factor-beta. J Bone Joint Surg Am 1995; 77: 1135–1147.
Canalis E, Centrella M, McCarthy T . Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 1988; 81: 1572–1577.
Kato T et al. Single local injection of recombinant fibroblast growth factor-2 stimulates healing of segmental bone defects in rabbits. J Orthop Res 1998; 16: 654–659.
Nakamura T et al. Recombinant human basic fibroblast growth factor accelerates fracture healing by enhancing callus remodeling in experimental dog tibial fracture. J Bone Miner Res 1998; 13: 942–949.
Radomsky ML, Thompson AY, Spiro RC, Poser JW . Potential role of fibroblast growth factor in enhancement of fracture healing. Clin Orthop 1998; 355 (Suppl): S283–S293.
Radomsky ML et al. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res 1999; 17: 607–614.
Nash TJ et al. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 1994; 15: 203–208.
Thaller SR, Dart A, Tesluk H . The effects of insulin-like growth factor-1 on critical-size calvarial defects in Sprague–Dawley rats. Ann Plast Surg 1993; 31: 429–433.
Trippel SB . Potential role of insulinlike growth factors in fracture healing. Clin Orthop 1998; 355 (Suppl): S301–S313.
Boden SD et al. Lumbar spine fusion by local gene therapy with a cDNA encoding a novel osteoinductive protein (LMP-1). Spine 1998; 23: 2486–2492.
Linkhart TA, Mohan S, Baylink DJ . Growth factors for bone growth and repair: IGF, TGF beta and BMP. Bone 1996; 19: 1S–12S.
Azari K et al. Therapeutic potential of bone morphogenetic proteins. Expert Opin Investig Drugs 2001; 10: 1677–1686.
Yoon ST, Boden SD . Osteoinductive molecules in orthopaedics: basic science and preclinical studies. Clin Orthop 2002; 395: 33–43.
Jane J et al. Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 2002; 6: 464.
Song JJ et al. Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation. Endocrinology 1995; 136: 4293–4297.
Ploemacher RE et al. Bone morphogenetic protein 9 is a potent synergistic factor for murine hemopoietic progenitor cell generation and colony formation in serum-free cultures. Leukemia 1999; 13: 428–437.
Lopez-Coviella I et al. Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP-9. Science 2000; 289: 313–316.
Dumont RJ et al. Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery 2002; 51: 1239–1245.
Peng Y et al. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 2003; 90: 1149–1165.